National Cancer Institute; Amended Notice of Meeting, 32744-32745 [2014-13100]

Download as PDF 32744 Federal Register / Vol. 79, No. 109 / Friday, June 6, 2014 / Notices wreier-aviles on DSK5TPTVN1PROD with NOTICES Inventors: Ana C. Souza (NIDDK), Peter S. Yuen (NIDDK), Robert A. Star (NIDDK), Alexander V. Bocharov (CC), Alan Remaley (NHLBI), Thomas Eggerman (NIDDK). Intellectual Property: HHS Reference No. E–743–2013/0—U.S. Application No. 61/890,585 filed 14 Oct 2013. Related Technology: HHS Reference No. E–114–2004/0. Licensing Contact: Lauren NguyenAntczak, Ph.D., J.D.; 301–435–4074; nguyenantczakla@mail.nih.gov. Collaborative Research Opportunity: The National Institute of Diabetes and Digestive and Kidney Diseases is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate or commercialize Treatment of Chronic Kidney Disease with 5A–37pA and Derivatives Thereof. For collaboration opportunities, please contact Marguerite Miller at marguerite.miller@nih.gov or 301–496– 9003. Novel Anti-HIV Proteins From Coral Reefs Description of Technology: The subject invention describes Cnidarins as a novel class of highly potent proteins capable of blocking the HIV virus from penetrating T-cells. Cnidarins were found in a soft coral collected in waters off Australia’s northern coast. Cnidarins can block virus fusion/entry but do not block viral attachment. In addition, Cnidarins do not have lectin-like activity and therefore possibly a unique mechanism of action. Thus, Cnidarins may represent important new leads for HIV microbicides or for systemic therapeutics for HIV. Potential Commercial Applications: Microbicide; Therapeutic; Research tool. Competitive Advantages: High potency against HIV; Novel chemical composition; Family of related proteins; Unique mechanism of action. Development Stage: Early-stage; In vitro data available; Prototype. Inventors: Barry O’Keefe, James McMahon, Koreen Ramessar, Chang-yun Xiong (all of NCI). Intellectual Property: HHS Reference No. E–295–2012/0—U.S. Provisional Patent Application No. 61/925,347 filed 09 Jan 2014. Licensing Contact: Sally H. Hu, Ph.D., M.B.A.; 301–435–5606; hus@ mail.nih.gov. Collaborative Research Opportunity: The National Cancer Institute is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate or commercialize large-scale recombinant production of cnidarins and evaluation VerDate Mar<15>2010 13:59 Jun 05, 2014 Jkt 232001 of their broader antiviral activity as well as additional pre-clinical studies. For collaboration opportunities, please contact John D. Hewes, Ph.D. at hewesj@ mail.nih.gov. Dated: June 2, 2014. Richard U. Rodriguez, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. 2014–13097 Filed 6–5–14; 8:45 am] BILLING CODE 4140–01–P deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS). DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: June 2, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2014–13098 Filed 6–5–14; 8:45 am] National Cancer Institute; Notice of meeting BILLING CODE 4140–01–P Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Cancer Institute Director’s Consumer Liaison Group. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. DEPARTMENT OF HEALTH AND HUMAN SERVICES Name of Committee: National Cancer Institute Director’s Consumer Liaison Group. Date: June 26, 2014. Time: 2:00 p.m. to 4:00 p.m. Agenda: NCI Update, Primer on Immunotherapy, Advocate and Organizational Engagement Working Group Discussion. Place: National Institutes of Health, Building 31, C-Wing, Rooms 9 & 10, 31 Center Drive, Bethesda, MD 20892 (Teleconference: 1–888–946–9419; Passcode: 9630125) Contact Person: Amy Bulman, National Cancer Institute, 31 Center Drive, Building 31, Room 10A28, Bethesda, MD 20892, 301– 496–9723, williaam@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Clinical Trials and Translational Research Advisory Committee, July 16, 2014, 09:00 a.m. to July 16, 2014, 04:00 p.m., National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD, 20892 which was published in the Federal Register on April 18, 2014, 79FR21938. The meeting is being amended to change the start and end times from 11:00 a.m. to 1:00 p.m. and the mode of the meeting is being changed from face to face to a webinar. Pertinent information related to the meeting is as follows: Date: Wednesday, July 16, 2014. Time: 11:00 a.m.–1:00 p.m., ET. Meeting Number: 730 782 390. Meeting Password: ctac. Join the online meeting (webinar/ video conference). Go to: https://cbiit.webex.com/cbiit/ j.php?MTID=m258581e041454e 26f5dbaaa63e54f2. Enter your name and email address. If required, enter the meeting password: ctac, then Click ‘‘Join’’. Follow the instructions that appear on your screen. If/when prompted to run a temporary application, click ‘‘Run’’. This may be a small window that pops up and allows you to click ‘‘Run’’. It may also be a small blue link to ‘‘Run a Temporary Application’’ on the WebEx screen. Connect to WebEx audio (phone line). Once you have joined the meeting, an Audio Conference window will appear with prompts to enter your number. E:\FR\FM\06JNN1.SGM 06JNN1 Federal Register / Vol. 79, No. 109 / Friday, June 6, 2014 / Notices Important: Provide your number (telephone number of where you are) when you join the meeting to receive a call back. Click ‘‘Call Me’’ and the session will call this number. Answer the phone when WebEx calls you, and press (1) to join the meeting (as prompted). Do NOT put your phone on HOLD. To MUTE your phone; either push: The Mute button on your phone or click ‘‘Mute Me’’ in the menu at the top of the screen. If you disconnect and later reconnect, follow the same procedures above to (1) Join the online meeting and (2) Connect to WebEx audio. If you are unable to be at a computer for this session or do not have internet access, you may call the following number: 1–240–276–6338 for Audio access ONLY. Please be sure to identify yourself if you are a CTAC Board Member. Dated: June 2, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–13100 Filed 6–5–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings wreier-aviles on DSK5TPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Systems Science and Health in the Behavioral and Social Sciences. Date: June 30, 2014. Time: 7:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Tomas Drgon, Ph.D., Scientific Review Officer, Center for VerDate Mar<15>2010 13:59 Jun 05, 2014 Jkt 232001 Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3152, MSC 7770, Bethesda, MD 20892, 301–435– 1017, tdrgon@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Research Project Grant. Date: June 30, 2014. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Martha L. Hare, Ph.D., RN, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3154, MSC 7770, Bethesda, MD 20892, (301) 451– 8504, harem@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, RFA AG– 14–008: Secondary Analyses of Social and Behavioral Datasets in Aging. Date: July 2, 2014. Time: 8:00 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Suzanne Ryan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 20892, (301) 435– 1712, ryansj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, RFA AG– 14–008 Secondary Analyses of Social and Behavioral Datasets in Aging. Date: July 2, 2014. Time: 9:00 a.m. to 11:00 a.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Karin F. Helmers, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3144, MSC 7770, Bethesda, MD 20892, (301) 254– 9975, helmersk@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, PAR Panel: Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival. Date: July 2, 2014. Time: 4:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Denise Wiesch, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3138, MSC 7770, Bethesda, MD 20892, (301) 437– 3478, wieschd@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 32745 Conflict: Societal and Ethical Issues in Research. Date: July 3, 2014. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Lisa Steele, Ph.D., Scientific Review Officer, PSE IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 20892, 301–594– 6594, steeleln@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS). Dated: June 2, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–13101 Filed 6–5–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [1651–0107] Agency Information Collection Activities: Application of Waiver of Passport and/or Visa U.S. Customs and Border Protection, Department of Homeland Security. ACTION: 60-Day Notice and request for comments; extension of an existing collection of information. AGENCY: U.S. Customs and Border Protection (CBP) of the Department of Homeland Security will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act: Application for Waiver of Passport and/or Visa (Form I–193). CBP is proposing that this information collection be extended with no change to the burden hours or to the information collected. This document is published to obtain comments from the public and affected agencies. DATES: Written comments should be received on or before August 5, 2014 to be assured of consideration. ADDRESSES: Direct all written comments to U.S. Customs and Border Protection, Attn: Tracey Denning, Regulations and Rulings, Office of International Trade, 90 K Street NE., 10th Floor, Washington, DC 20229–1177. SUMMARY: E:\FR\FM\06JNN1.SGM 06JNN1

Agencies

[Federal Register Volume 79, Number 109 (Friday, June 6, 2014)]
[Notices]
[Pages 32744-32745]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-13100]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National
Cancer Institute Clinical Trials and Translational Research Advisory
Committee, July 16, 2014, 09:00 a.m. to July 16, 2014, 04:00 p.m.,
National Institutes of Health, Building 31, 31 Center Drive, Bethesda,
MD, 20892 which was published in the Federal Register on April 18,
2014, 79FR21938.
The meeting is being amended to change the start and end times from
11:00 a.m. to 1:00 p.m. and the mode of the meeting is being changed
from face to face to a webinar. Pertinent information related to the
meeting is as follows:
Date: Wednesday, July 16, 2014.
Time: 11:00 a.m.-1:00 p.m., ET.
Meeting Number: 730 782 390.
Meeting Password: ctac.
Join the online meeting (webinar/video conference).
Go to: https://cbiit.webex.com/cbiit/j.php?MTID=m258581e041454e26f5dbaaa63e54f2. Enter your name and email
address. If required, enter the meeting password: ctac, then Click
``Join''. Follow the instructions that appear on your screen. If/when
prompted to run a temporary application, click ``Run''. This may be a
small window that pops up and allows you to click ``Run''. It may also
be a small blue link to ``Run a Temporary Application'' on the WebEx
screen. Connect to WebEx audio (phone line).
Once you have joined the meeting, an Audio Conference window will
appear with prompts to enter your number.

[[Page 32745]]

Important: Provide your number (telephone number of where you are) when
you join the meeting to receive a call back. Click ``Call Me'' and the
session will call this number. Answer the phone when WebEx calls you,
and press (1) to join the meeting (as prompted).
Do NOT put your phone on HOLD. To MUTE your phone; either push: The
Mute button on your phone or click ``Mute Me'' in the menu at the top
of the screen.
If you disconnect and later reconnect, follow the same procedures
above to (1) Join the online meeting and (2) Connect to WebEx audio.
If you are unable to be at a computer for this session or do not
have internet access, you may call the following number: 1-240-276-6338
for Audio access ONLY. Please be sure to identify yourself if you are a
CTAC Board Member.

Dated: June 2, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-13100 Filed 6-5-14; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.